Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives - Takeaways - MDSpire

Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives

  • By

  • Wen, Jianting

  • Liu, Jian

  • June 8, 2026

  • 0 min

Share

  • 1

    Tripterygium wilfordii Hook. f. (TWHf) is traditionally used for rheumatoid arthritis (RA) but requires a comprehensive understanding of its efficacy and safety.

  • 2

    The review summarizes clinical evidence and mechanisms of TWHf-derived compounds, including Tripterygium Glycosides Tablets and Xinfeng Capsule in RA management.

  • 3

    Preclinical studies show TWHf compounds regulate RA-related processes through various signaling pathways and immune responses.

  • 4

    Xinfeng Capsule demonstrates broader regulatory effects compared to isolated monomers, enhancing efficacy and reducing toxicity.

  • 5

    Challenges in TWHf application include toxicity, lack of high-quality trials, and need for standardized formulations and personalized dosing.

Original Source(s)

Tripterygium wilfordii Hook. f. and Xinfeng Capsule in Rheumatoid Arthritis: A Review of Clinical Evidence, Molecular Mechanisms, and Translational Perspectives

  • by Wen, Jianting , Liu, Jian

  • June 8, 2026

Related Content

Culture Mismatch Common in Joint Infections

Multicenter study suggests variability across centers and higher mismatch in certain clinical settings.

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.